Skip to main content
. 2022 Nov 1;13:1016776. doi: 10.3389/fimmu.2022.1016776

Figure 1.

Figure 1

The proportion and phenotype of MDSCs after cryo-thermal therapy. (A) The proportion of splenic MDSCs on day 21 after cryo-thermal therapy. (B, C) The expression levels of CD86 and MHC-II (B), CD11c, and F4/80 (C) on MDSCs from tumor-bearing control (gray) and cryo-thermal therapy (solid line) were detected by flow cytometry. (D) The expression levels of functional molecules of MDSC were detected by qRT-PCR. *p < 0.05, ***p < 0.001. n = 4 for each group. MDSCs, myeloid-derived suppressive cells.